GW Pharmaceuticals to Report Second Quarter Financial Results and Host Conference Call on 8 May, 2018
LONDON, May 03, 2018 (GLOBE NEWSWIRE) -- GW Pharmaceuticals plc (Nasdaq:GWPH) (“GW” or “the Company”), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform, …